Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake
about
Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugsAmphetamine, past and present--a pharmacological and clinical perspectiveBiochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemideInteraction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitroVasopressin-dependent flank marking in golden hamsters is suppressed by drugs used in the treatment of obsessive-compulsive disorderNeurotransmitter and psychostimulant recognition by the dopamine transporter.Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPgammaS bindingEffects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitroEffects of lidocaine-induced inactivation of the bed nucleus of the stria terminalis, the central or the basolateral nucleus of the amygdala on the opponent-process actions of self-administered cocaine in ratsHyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.Differential effect of quinpirole and 7-OH-DPAT on the spontaneous [(3)H]-dopamine efflux from rat striatal synaptosomes.Differential inhibitory effects of drugs acting at the noradrenaline and 5-hydroxytryptamine transporters in rat and human neocortical synaptosomesUsing In Vivo Electrochemistry to Study the Physiological Effects of Cocaine and Other Stimulants on the Drosophila melanogaster Dopamine Transporter.Citalopram--a review of pharmacological and clinical effects.Reboxetine: a selective norepinephrine reuptake inhibitor for the treatment of depression.Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder.Drug dependence: neuropharmacology and management.Development of potent dopamine-norepinephrine uptake inhibitors (DNRIs) based on a (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol molecular template.Amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo.Monoamine reuptake inhibitors in Parkinson's disease.Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study.Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.SKF-83566, a D1-dopamine receptor antagonist, inhibits the dopamine transporter.Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices.Increasing TNF levels solely in the rat hippocampus produces persistent pain-like symptomsX-ray structures of Drosophila dopamine transporter in complex with nisoxetine and reboxetine.Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice.Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatmentsThe effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat.Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood.Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neuronsEffects of pregnanolone in rats discriminating cocaine.Animal model of methylphenidate's long-term memory-enhancing effects.A review of late-stage CNS drug candidates for the treatment of obesity.Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned?Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of Nonhuman Primate Studies and Clinical Trials.High doses of amphetamine augment, rather than disrupt, exocytotic dopamine release in the dorsal and ventral striatum of the anesthetized rat.Activation and desensitization of presynaptic alpha 2-adrenoceptors after inhibition of neuronal uptake by antidepressant drugs in the rat vas deferens.Differential effects of cocaine on dopamine neuron firing in awake and anesthetized rats.Bupropion and Citalopram in the APP23 Mouse Model of Alzheimer's Disease: A Study in a Dry-Land Maze.
P2860
Q21262013-56AC8FC4-B326-46C3-A618-8575F537D6A3Q22241826-A458437F-4F41-445A-934E-EBE4AAF669B8Q24535668-9FD88083-148D-4ED4-B3BD-158E4EEE0580Q24680063-6F8B0A0A-92FC-4B28-A2A8-5AA85AB9185EQ24803880-E7DE9E5A-2BDA-4F44-8A3C-89986D9E82B0Q27316816-1FC2A3EC-8DC2-41EC-98D1-A740C463EA4CQ28250122-E8CA575B-B085-4B9E-9BD1-757FE18D20CFQ28267806-E62591E0-C39C-4FCE-8144-5D7B6A932993Q30464299-F15A4900-5E6B-439E-8893-24863253EC1EQ30475347-83E92D18-C560-4938-8705-157EAA2D6936Q31913355-3EF753C0-F10F-48DD-9B2D-6A26122AB03FQ33569581-6E5DA226-82F0-402A-A25A-828C06037920Q33746985-F348B285-93B7-4CE1-957A-AED4B29FA8D7Q33948515-BD66DD6A-7BE2-45E5-9E7A-84493187B775Q34093609-8F9B483F-EEC1-478B-A3FD-A1D33B69175EQ34251275-05BFA24A-51A6-4E1B-91FA-046AD6E299EBQ34773986-127218B1-2FB1-4F58-BAF3-2E0F8DB3948BQ35054544-5FDB67CF-4006-4C35-83E1-3DDCE2BC9F3BQ35099218-612EAC38-9FE9-4D71-9947-EE83A94CEAB8Q35165280-8F46DE41-5311-47BF-8B1E-D8A5D8B5F4DBQ35448551-69AA8E00-09FA-45C7-AF98-02400B4FE391Q35908982-47D601D6-9765-4A50-B588-FAA83C6DE10DQ35915923-BC17042A-095B-4BA2-847D-72D47499E9BAQ36092017-CEDA2E3D-98A3-4DD5-9C0A-EF046D097817Q36160364-53B1BC93-F76C-4C36-86E3-466E88C54AC4Q36170340-B09349CE-43AB-4C98-B066-93B0935B7EA2Q36603189-F6F9ADC1-BF35-43F2-B224-B3E62AE75E3CQ36681100-23E89871-584E-4DCE-8DB8-7AA98D75E7F7Q36755071-A029961B-142B-450D-8DD7-442223B977F4Q37005445-1ED1E687-AB16-4F64-AD08-8C5FD2C2C340Q37236791-B6B263EF-561B-45E9-BFD6-ED8DBB8855C5Q37251129-8BDA12C1-106B-4727-A26E-880FF785C5BCQ37491483-AD488E44-5AB1-4E68-B01A-D5BE74E791A7Q37992857-CA26DDE8-B70D-4156-8619-A1008F42BCF0Q38087534-9BFD6980-8358-4832-AE4E-3972E30ABE24Q38837020-C30FAC70-F8F0-437E-9286-FC5E3CB22F86Q39027124-80EA9B9B-7437-4CC5-BDEB-2500A8C4E61BQ41810727-E93DE94D-A86B-435E-9079-B9C84161E7E6Q41829457-4E503572-801D-4072-9432-A11BBF211D83Q41860053-BA4AD440-351D-40B1-88A2-B13F176F8AE4
P2860
Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake
description
1984 nî lūn-bûn
@nan
1984 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Blockade by antidepressants an ...... ly block norepinephrine uptake
@ast
Blockade by antidepressants an ...... ly block norepinephrine uptake
@en
Blockade by antidepressants an ...... ly block norepinephrine uptake
@nl
type
label
Blockade by antidepressants an ...... ly block norepinephrine uptake
@ast
Blockade by antidepressants an ...... ly block norepinephrine uptake
@en
Blockade by antidepressants an ...... ly block norepinephrine uptake
@nl
prefLabel
Blockade by antidepressants an ...... ly block norepinephrine uptake
@ast
Blockade by antidepressants an ...... ly block norepinephrine uptake
@en
Blockade by antidepressants an ...... ly block norepinephrine uptake
@nl
P1476
Blockade by antidepressants an ...... ly block norepinephrine uptake
@en
P2093
E Richelson
M Pfenning
P304
P356
10.1016/0014-2999(84)90403-5
P407
P577
1984-09-17T00:00:00Z